The treatment of bronchiolitis

Archives of Disease in Childhood

Volumn 93, Issue 9, 2008, Pages 793-798

  Yanney, M ^a   Vyas, Harish ^b  

^a SHERWOOD FOREST HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ANTIBIOTIC AGENT; BERACTANT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CAFFEINE; CORTICOSTEROID; DEXAMETHASONE; HELIOX; IMMUNOGLOBULIN; METHYLXANTHINE DERIVATIVE; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN; SALBUTAMOL; THEOPHYLLINE;

ACUTE RESPIRATORY FAILURE; BOCAVIRUS; BRONCHIOLITIS; CHILD HOSPITALIZATION; CLINICAL TRIAL; DRUG MEGADOSE; EXTRACORPOREAL OXYGENATION; FLUID RETENTION; HOSPITAL ADMISSION; HUMAN; HUMAN METAPNEUMOVIRUS; IMMUNOPROPHYLAXIS; INTENSIVE CARE; INTERMITTENT POSITIVE PRESSURE VENTILATION; LOW DRUG DOSE; NONHUMAN; NORTH AMERICA; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED KINGDOM; VIRUS ISOLATION;

BOCAVIRUS; BRONCHIOLITIS, VIRAL; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; GLYCOPROTEINS; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; MALE; PHENOTYPE; PICORNAVIRIDAE INFECTIONS; PROGNOSIS; RESPIRATORY INSUFFICIENCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINOVIRUS; TREATMENT OUTCOME; VIRAL PROTEINS;

EID: 51449123396     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.128736     Document Type: Review

References (62)

1. Paediatric Intensive Care Audit Network. PICANet Annual General Meeting. June 2006. http://www.picanet.org.uk/Documents/General/AGM_2006/ PICAnet%20bronchiolitis%202.pdf (accessed 20 June 2008).
2. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. Philadelphia: WB Saunders, 1998:2084-111.
3. Handforth J, Friedland JS, Sharland M. Basic epidemiology and immunopathy of RSV in children. Paediatr Respir Rev 2000;1:210-14.
4. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis- associated hospitalizations among US children, 1980-1996. JAMA 1999;282(15):1440-6.
5. McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings and family history of asthma increase risk of bronchiolitis. Am J Dis Child 1986;140(8):806-12.
6. Holman RC, Curns AT, Cheek JE, et al. Respiratory syncytial virus hospitalizations among American Indian and Alaska native infants and the general United States infant population. Pediatrics 2004;114(4): e437-44.
7. Figueras-Aloy J, Carbonell-Estrany X, Quero J. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J 2004;23(9):815-20.
8. Choudhuri JA, Ogden LG, Ruttenber AJ, et al. Effect of altitude on hospitalizations for respiratory syncytial virus infection. Pediatrics 2006;117(2):349-56.
9. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986;315(2):77-81.
10. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982;307(7):397-400.
11. Shaw KN, Bell LM, Sherman NH. Outpatient assessment of infants with bronchiolitis. Am J Dis Child 1991;145(2):151-5.
12. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995;126(2):212-19.
13. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J 2003;22(2 Suppl):S40-4.
14. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human metapneumovirus isolated from young children with respiratory tract disease. Nat Med 2001;7(6):719-24.
15. Foulongne VP, Guyon GM, Rodiere MM, et al. Human metapneumovirus infection in young children hospitalized with respiratory tract disease. Pediatr Infect Dis J 2006;25(4):354-9.
16. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350(5):443-50.
17. Jartti T, Makela MJ, Vanto T, et al. The link between bronchiolitis and asthma. Infect Dis Clin North Am 2005;19:667-89.
18. Allander T, Emerson SU, Engle RE, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 2005;102(36):12891-6.
19. Gardner PS. Virus infections and respiratory disease of childhood. Arch Dis Child 1968;43:629-45.
20. Behrendt CE, Decker MD, Burch DJ, et al. International variation in the management of infants hospitalised with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998;157:215- 20.
21. Navas L, Wang E, De Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 1992;121(3):348-54.
22. Stretton M, Ajizian S, Mitchell I, et al. Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol 1992;13:143-50.
23. Tasker RC, Gordon I, Kiff K. Time course of severe respiratory syncytial virus infection in mechanically ventilated infants. Acta Paediatr 2000;89(8):938-41.
24. Aherne W, Bird T, Court SD, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970;23:7-18.
25. Kim HW, Canchola JG, Brandt CD, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969;89:422-34.
26. Kapikian AZ, Mitchell RH, Chanock RM, et al. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS vaccine. Am J Epidemiol 1969;89:405-21.
27. Groothuis JR, Simoes E, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993;329(21):1524-30.
28. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102(3):531-7.
29. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant heart disease. J Pediatr 2003;143:532-40.
30. Kimpen JL. Prevention and treatment of respiratory syncytial virus bronchiolitis and post bronchiolitis wheezing. Respir Res 2002;3(Suppl 1):S40-5.
31. Greenough A, Alexander J, Burgess S, et al. Health care utilisation of prematurely bom, preschool children related to hospitalisation for RSV infection. Arch Dis Child 2004;89(7):673-8.
32. Patel H, Platt R, Lozano JM, et al Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004;(3):CD004878.
33. Cornell HM, Zorc JJ, Mahajan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357:331-9.
34. Kellner JD, Ohlsson A, Gadomski AM, et al. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2000;(2):CD001266.
35. Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003;349(1):27-35.
36. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995;126(6):1004-7.
37. Hartling L, Wiebe N, Russell K, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2004;(1):CD003123.
38. Ramosh P, Samuels M. Are methylxanthines effective in preventing or reducing apnoeic spells in infants with bronchiolitis? Arch Dis Child 2005;90(3):321-2.
39. Royal Children's Hospital Melbourne. The use of aminophylline in infants with bronchiolitis, http://www.rch.org.au/neonatal_rch/research.cfm? doc_id=6944 (last updated 11 December 2006) (accessed 20 June 2008).
40. Spurling GK, Fonseka K, Doust J. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev 2001;(1):CD005189.
41. Groothuis JR, Woodin KA, Katz R, et al. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr 1990;117(5):792-8.
42. Law BJ, Wang EEL, MacDonald N, et al. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV database. Pediatrics 1997;99(3):e7.
43. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2007;(1):CD000181.
44. Kneyber M, Moll H, de Groot R. Treatment and prevention of respiratory syncytial virus infection. Eur J Pediatr 2000;159:399- 411.
45. Downes JJ, Wood DW, Striker TW, et al. Acute respiratory failure in infants with bronchiolitis. Anesthesiology 1968;29(3):426-34.
46. Beasley JM, Jones SEF. Continuous positive airway pressure in bronchiolitis. BMJ 1981;283:1506-8.
47. Al-balkhi A, Klonin H, Marinaki K, et al. Review of treatment of bronchiolitis related apnoea in two centres. Arch Dis Child 2005;90:288-91.
48. Duval EL, Leroy PL, Gemke RJ, et al. High-frequency oscillatory ventilation in RSV bronchiolitis patients. Respir Med 1999;93(6):435-40.
49. Flamant C, Hallalel F, Nolent P, et al. Severe respiratory syncytial virus bronchiolitis in children: from short mechanical ventilation to extracorporeal membrane oxygenation. Eur J Pediatr 2005;164(2):93- 8.
50. Cambonie G, Milesi C, Fournier-Favre S, et al. Clinical effects of heliox administration for acute bronchiolitis in young infants. Chest 2006;129(3):676-82.
51. Liet JM, Millotte B, Tucci M, et al. Noninvasive therapy with helium-oxygen for severe bronchiolitis. J Pediatr 2005;147(6):812-17.
52. Tibby SM, Hatherill M, Wright SM, et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000;162(4):1251-6.
53. Outwater KM, Crone RK. Management of respiratory failure in infants with acute viral bronchiolitis. Am J Dis Child 1984;138:1071-5.
54. Label MH, Gauthier M, Lacroix J, et al. Respiratory failure and mechanical ventilation in severe bronchiolitis. Ach Dis Child 1989;64(10):1431-7.
55. Soong WJ, Hwang B, Tang RB. Continuous positive airway pressure by nasal prongs in bronchiolitis. Pediatr Pulmonol 1993;16:163-6.
56. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354(9178):541-5.
57. Noble V, Murray M, Webb MS, et al. Respiratory status and allergy nine to 10 years after bronchiolitis. Arch Dis Child 1997;76:315-19.
58. Sims DG, Downham MA, Gardner PS, et al. Study of 8 year old children with a history of respiratory syncytial virus bronchiolitis in infancy. BMJ 1978;1:11-14.
59. Kotaniemi-Syrjanen A, Vaiionpaa R, Reijonen TM, et al. Rhinovirus-induced wheezing in infancy-the first sign of childhood asthma? J Allergy Clin Immunol 2003;111(1):66-71.
60. Piedimonte G, Rodriguez M, King K, et al. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol 1999;277:L831-40.
61. Young S, O'Keeffe P, Arnott J, et al. Lung function, airway responsiveness and respiratory symptoms before and after bronchiolitis. Arch Dis Child 1995;72:16-24.
62. Elphick HE, Ritson S, Rigby AS, et al. Phenotype of acute respiratory syncytial virus induced lower respiratory tract illness in infancy and subsequent morbidity. Acta Paediatr 2007;96(2):307-9.